TFPI Monoklonaler Antikörper
TFPI Monoklonal Antikörper für WB, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgG2a
Getestete Reaktivität
human
Anwendung
WB, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1B12F11
Kat-Nr. : 66842-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66842-1-PBS bindet in WB, IF/ICC, Indirect ELISA TFPI und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Maus / IgG2a |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | TFPI fusion protein Ag14980 |
| Vollständiger Name | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
| Berechnetes Molekulargewicht | 251aa,29 kDa; 304aa,35 kDa |
| Beobachtetes Molekulargewicht | 35-38 kDa |
| GenBank-Zugangsnummer | BC015514 |
| Gene symbol | TFPI |
| Gene ID (NCBI) | 7035 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Tissue factor pathway inhibitor (TFPI) is a critical anticoagulant protein present in endothelium and platelets. TFPI is produced as two major isoforms in humans, TFPIa and TFPIb that result from alternative splicing. The TFPIb isoform localizes to the endothelium surface where it is a potent inhibitor of tissue factor-factor VIIa complexes that initiate blood coagulation. The TFPIa isoform is present in platelets. TFPI is a Kunitz-type serine protease inhibitor that exerts anticoagulant activity by blocking early procoagulant stimulia. TFPI can enhance anti-thrombotic treatment in sepsis, inflammatory diseases, and cardiovascular diseases.







